eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2009
vol. 34
 
Share:
Share:

Experimental immunology
The in vivo effect of Rhodiola rosea and Rhodiola quadrifida hydro-alcoholic extracts on chemokinetic activity of spleen lymphocytes in mice

Ewa Skopińska-Różewska
,
Małgorzata Bychawska
,
Beata Białas-Chromiec
,
Ewa Sommer

Centr Eur J Immunol 2009; 34 (1): 42-45
Online publish date: 2009/03/31
Article file
Get citation
 
 
Introduction
Rhodiola rosea (RR) and Rhodiola quadrifida (RQ) belong to the big family of adaptogenic herbs, comprising medicinal plants from various species – Panax ginseng, Schizandra chinensis, Eleutherococcus senticosus and many others. Rhodiola rosea is considered to be one of the most active adaptogenic drugs. Adaptogenic plants are used in traditional medicine to decrease depression, to enhance work performance and resistance to high-altitude illness, and to treat consequences of physical and psychological stress [1-7].
Besides of this stimulatory action on the nervous system, adaptogenic plants also have immunotropic activity [8-16]. Our earlier experimental studies documented immunomodulatory effects of extracts from Panax ginseng, Eleutherococcus senticosus, Schizandra chinensis and three Rhodiola species (R. rosea, R. quadrifida and R. kirilowii) on various parameters of immunological response in vivo and in vitro [17-30]. In the present paper we evaluate the in vivo influence of Rhodiola rosea and Rhodiola quadrifida hydro-alcoholic extracts on chemokinetic activity of mice splenic lymphocytes in vitro.

Material and Methods
Rhodiola rosea (Crassulaceae) roots and rhizomes were cultivated, collected and identified in the Research Institute of Medicinal Plants (RIMP), Poznań, thanks to prof. Przemysław M. Mrozikiewicz and dr Waldemar Buchwald.
Rhizomes of R. quadrifida were collected in Altai mountain in Mongolia, thanks to dr H. Wiedenfeld. The Mongolian plant material was identified; voucher specimen was deposited at the herbarium of the Institute of Botany of Mongolian Academy of Science in Ulaanbatar. Samples for the study were obtained by Prof. Mirosława Furmanowa, head of the scientific project PBZ-KBN-092/PO5/2003. Sample extractions and their chemical analysis were performed by the scientists from RIMP (dr Alina Mścisz, dr Anna Krajewska-Patan, dr Sebastian Mielcarek), and from Warsaw Medical University (prof. Mirosława Furmanowa, dr Małgorzata Hartwich, dr Marek Malinowski) as was described before [24, 25, 30]. Briefly: air-dried finely powdered roots and rhizomes were extracted two times with 50% ethanol (hydro-alcoholic extracts, RRA and RQA), at 40-45°C, evaporated to dryness and lyophilized. For the study of chemical composition of extracts HPLC methods have been used [31, 32]. Extracts were dissolved in 10% ethyl alcohol before administration to the animals.
The study was performed on 8-10-weeks old female inbred Balb/c mice, 20-22 g of body mass, delivered from the Polish Academy of Sciences breeding colony.
For all experiments animals were handled according to the Polish law on the protection of animals and NIH (National Institutes of Health) standards. All experiments were accepted by the local Ethical Committee.

Rhodiola extracts were administered to Balb/c mice per os in 7 daily doses of 40 or 200 mg (each group consisted of 8 mice). These doses corresponded to 20 or 100 mg given to 70 kg person (applying the coefficient equal 7 for adjusting differences between mouse and human in relation of the surface to body mass). Mice received drugs by Eppendorff pipette, in 40 ml of 10 % ethyl alcohol, for 7 days. Control mice (16 animals) were fed 40 ml of 10% ethyl alcohol. On the day 8th mice were bled in anaesthesia from retro-orbital plexus and sacrificed with Morbital. Splenocytes were isolated from spleens under sterile conditions by straining through stainless sieve and cotton gauze and centrifugation on Lymphoprep in order to remove erythrocytes.
Spleen cells chemokinesis (spontaneous migration) assay in vitro was performed according to the Sandberg method [33] in own modification [19, 23]. Briefly, isolated splenocytes were resuspended in Parker culture medium with 5% inactivated FCS, at the final concentration of 30×106 cells/ml. Afterwards, siliconized capillary tubes were filled with cell suspension, sealed with plasticine, centrifuged (5 min 450 g) and fixed on the glass plates. Cells levels were marked. After 24 h incubation (37°C, 5% CO2 humidified atmosphere) the distances of migration were measured in milimeters (mm) at a magnification of 6.5 × and presented as migration units (1 MU= 0.18 mm).
Stimulatory indices were calculated by dividing the results obtained for individual splenocytes cultures derived from Rhodiola fed animals by the mean of the results of accompanying control cultures.
Statistical evaluation of the results was done by 2-way analysis of variance (ANOVA) and Bonferroni post-test (GraphPad Prism software package).

Results
Performed analysis of variance revealed, that variation among column means is highly significantly greater than expected by chance (Table 1). Bonferroni Multiple Comparison Test indicated differences between control group and groups of mice fed 0.04 mg daily dose of both extracts. Higher 0.2 mg dose was ineffective in the case of Rhodiola rosea (RRA) extract (Table 2 and Fig. 1).

Discussion
The aim of this study was to evaluate, for the first time, the in vivo effect of extracts obtained from the roots and rhizomes of R. rosea and R. quadrifida on chemokinetic activity of mice splenocytes in 24 h tissue cultures in vitro. The results obtained show higher in vitro migratory activity of splenocytes collected from mice fed lower dose of Rhodiola extracts. It may reflect the higher incidence in these cell suspensions of T lymphocytes, having better migratory properties than B cells.
Earlier experiments performed by us with some other plant adaptogens (extracts from Eleutherococcus senticosus, Centella asiatica, Lithospermum canescens) revealed stimulatory effect of lower doses and no effect or inhibitory influence of higher doses of these substances on mobility of splenocytes of treated mice [17, 19]. In the present study we observed similar effects. Moreover, our earlier studies on various other parameters of cellular specific and nonspecific immune response in mice, rats and pigs, revealed that Rhodiola extracts in vivo and in vitro enhanced these responses in lower doses and were ineffective or suppressed them in higher ones [24, 25, 27]. In experiments in mice, feeding cell donors 400 mg daily doses of R. rosea extracts resulted in suppression of splenic lymphocytes angiogenic activity, what may suggest the presence of suppressor cells or production of suppressory cytokines. This dose corresponds to the doses recommended by producers of some dietary supplements which contain Rhodiola rosea (Antystress, Lentaya) [24]. In the case of R. quadrifida hydro-alcoholic extract, the best stimulation of lymphocytes angiogenic activity was obtained feeding mice 200 mg daily dose (what corresponds to 100 mg of human dose). Dose of 400 mg was not inhibitory, as in the case of R. rosea, but gave lower stimulatory effect [25]. It corresponds to the effects obtained by us for these two Rhodiolas in the present work.

Conclusion
In human, daily doses 20 mg, 50 mg (and in the case of R. quadrifida also 100 mg) of Rhodiola extracts would effectively stimulate lymphocyte-dependent immunity. Use of dietary supplements containing R. rosea in daily doses higher than 50 mg, might be dangerous because of the possibility of suppression of some lymphocyte activities. However, anti-bacterial activity of peritoneal macrophages increased in mice fed 400 mg of Rhodiola rosea extracts [in press], and metabolic activity of mice blood granulocytes fed R. quadrifida presented dose-dependent increase up to the 400 mg daily dose [28].

References
1. Monograph (2002): Rhodiola rosea. Altern Med Rev 7: 421-423.
2. Monograph (2006): Eleutherococcus senticosus. Altern Med Rev 11: 151-155.
3. Single Herb Monographs: Ginseng. http://www.tufts.edu/med/ebcam/east-AsianMed/Ginseng/html.
4. Perfumi M, Mattioli L (2007): Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytother Res 21: 37-43.
5. Lee S, Kim DH, Jung JW et al. (2007): Schizandra chinensis nand Scutellaria balcalensis counter stress behaviours in mice. Phytother Res 21: 1187-1192.
6. Panossian A, Wagner H (2005): Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration. Phytother Res 19: 819-38.
7. PanossianA, Wikman G (2008): Pharmacology of Schizandra chinensis Ball: an overview of Russian research and uses in medicine. J Ethnopharmacol 118: 183-212.
8. Pooja BA, Khanum F (2009): Anti-inflammatory activity of Rhodiola rosea – “a sedond-generation adaptogen”. Phytother Res Jan 16 (Epub ahead of print).
9. Biondo PD, Robbins SJ, Walsh JD (2008): A randomized controlled crossover trial of the effect of ginseng consumption on the immune response to moderate excercise in healthy sedentary men. Appl Physiol Nutr Metab 33: 966-975.
10. Kormosh N, Laktionov K, Antoshechkina M (2006): Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer. Phytother Res 20: 424-425.
11. Guo LY, Hung TM, Bae KH et al. (2008): Anti-inflammatory effects of schisandrin isolated from the fruit of Schisandra chinensis Ball. Eur J Pharmacol 59: 293-299.
12. Song X, Bao S, Wu L, Hu S (2009): Ginseng stem-leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice. Vaccine 27: 51-55.
13. Lim DS, Bae KG, Jung IS et al. (2002): Anti-septicaemic effect of polysaccharide from Panax ginseng by macrophage activation. J Infect 45: 32-38.
14. Wang H, Actor JK, Indrigo J et al. (2003): Asian and Siberian ginseng as a potential modulator of immune function: an in vitro cytokine study using mouse macrophages. Clin Chim Acta 327: 123-128.
15. Liou CJ, Huang WC, Tseng J (2006): Short-term oral administration of ginseng extract induces type-1 cytokine production. Immunopharmacol Immunotoxicol 28: 227-240.
16. Chen TS, Liou SY, Chang YL (2008): Antioxidant evaluation of three adaptogen extracts. Am J Chin Med 36: 1209-1217.
17. Pietrosiuk A, Skopińska-Różewska E, Furmanowa M (2004): Immunomodulatory effect of shikonin derivatives isolated from Lithospermum canescens on cellular and humoral immunity in Balb/c mice. Pharmazie 59: 640-642.
18. Furmanowa M, Skopińska-Różewska E, Rogala E, Hartwich M (1998): Rhodiola rosea in vitro culture-phytochemical analysis and antioxidant action. Acta Soc Botanic Pol 67: 69-73.
19. Rogala E, Skopińska-Różewska E, Sawicka T et al. (2003): The influence of Eleutherococcus senticosus on cellular and humoral immunological response of mice. Pol J Vet Sci 6 (Suppl): 37-39.
20. Skopińska-Różewska E, Nartowska J, Augustynowicz J et al. Żeńszeń w świetle współczesnych badań naukowych. In: Immunomodulacja – nowe możliwości w ochronie zdrowia. Eds. Siwicki AK, Skopińska-Różewska E, Świderski F. SPW EDYCJA, Olsztyn 2004; pp. 21-27.
21. Siwicki AK, Skopińska-Różewska E, Nartowska J et al. (2004): Effect of Immunostim plus – a standardized fixed combination of Schizandra chinensis with Eleutherococcus senticosus extracts on granulocyte activity and tumor angiogenesis in mice. Bull Vet Inst Pulawy 48: 489-492.
22. Rogala E, Sommer E, Radomska-Leśniewska D et al. (2004): Immunomodulatory effects of Panax ginseng preparations on the mouse. Herba Polonica 50: 38-44.
23. Skopińska-Różewska E, Siwicki AK, Wójcik R et al. (2006): Immunostimulatory effect of Immunostim-plus – a standardized fixed combination of Schizandra chinensis with Eleutherococcus senticosus extracts on lymphocyte – dependent cellular immunity in mice. Bull Vet Inst Pulawy 50: 461-465.
24. Siwicki AK, Skopińska-Różewska E, Hartwich M et al. (2007): The influence of Rhodiola rosea extracts on non-specific and specific cellular immunity in pigs, rats and mice. Centr Eur
J Immunol 32: 84-91.
25. Skopińska-Różewska E, Wójcik R, Siwicki AK (2008): The effect of Rhodiola quadrifida extracts on cellular immunity in mice and rats. Pol J Vet Sci 11: 105-111.
26. Skopińska-Różewska E, Malinowski M, Wasiutyński A et al. (2008): The influence of Rhodiola quadrifida 50% hydro-alcoholic extract and salidroside on tumor-induced angiogenesis in mice. Pol J Vet Sci 11: 97-104.
27. Wójcik R, Siwicki AK, Skopińska-Różewska E et al. (2008): The in vitro influence of Rhodiola quadrifida extracts on non-specific cellular immunity in pigs. Centr Eur J Immunol 33: 193-196.
28. Skopińska-Różewska E, Bychawska M, Sommer E, Siwicki AK (2008): The in vivo effect of Rhodiola quadrifida extracts on the metabolic activity of blood granulocytes in mice. Centr Eur
J Immunol 33: 179-181.
29. Skopińska-Różewska E, Wasiutyński A, Sommer E et al. (2008): The influence of R. rosea, R. kirilowii and R. quadrifida extracts on cutaneous angiogenesis induced in mice after grafting of human kidney cancer tissue. Centr Eur J Immunol 33: 185-189.
30. Skopińska-Różewska E, Hartwich M, Siwicki AK et al. (2008): The influence of Rhodiola rosea extracts and rosavin on cutaneous angiogenesis induced in mice after grafting of syngeneic tumor cells. Centr Eur J Immunol 33: 102-107.
31. Mielcarek S, Mścisz A, Buchwald W et al. (2005): Phytochemical investigation of Rhodiola sp. Root extracts. Herba Polonica 51 (Suppl 1): 159.
32. Wiedenfeld H, Dumaa M, Malinowski M, Furmanowa M (2007): Phytochemical and analytical studies of extracts from Rhodiola rosea and Rhodiola quadrifida. Pharmazie 62: 308-311.
33. Sandberg G (1976): The sealed capillary migration technique and thymocyte migration in vitro. J Immunol Meth 12: 365-368.
Copyright: © 2009 Polish Society of Experimental and Clinical Immunology This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.